	Passifs Courants		Date
Acadia Pharmaceuticals	USD 277.11M	79.47M	2025-12
Alnylam Pharmaceuticals	USD 1.47B	89.13M	2025-12
Amgen	USD 25.49B	3.7B	2025-12
BioCryst Pharmaceuticals	USD 190.24M	13.08M	2025-09
Biogen	USD 3.35B	59.4M	2025-12
BioMarin Pharmaceutical	USD 759.03M	39.41M	2025-12
Cytokinetics	USD 202.45M	60.31M	2025-12
Daiichi Sankyo	JPY 778.55B	77.51B	2025-12
Enanta Pharmaceuticals	USD 44.73M	3.83M	2025-12
Esperion Therapeutics	USD 359.03M	60.24M	2025-09
Gilead Sciences	USD 11.81B	485M	2025-12
Incyte	USD 1.52B	176.44M	2025-12
Ionis Pharmaceuticals	USD 783M	120.46M	2025-12
Ironwood Pharmaceuticals	USD 242.5M	9.98M	2025-09
Karyopharm Therapeutics	USD 87.16M	12.06M	2025-09
Novartis	USD 32B	286M	2025-09
Pfizer	USD 36.6B	1.13B	2025-09
PTC Therapeutics	USD 968.43M	102.18M	2025-12
Puma Biotechnology	USD 82.73M	3.63M	2025-09
Roche Holding	CHF 28B	421M	2025-12
Sangamo BioSciences	USD 47.66M	1.9M	2025-06
Sarepta Therapeutics	USD 1.1B	173.86M	2025-12
TG Therapeutics	USD 153.76M	3.05M	2025-12
Ultragenyx Pharmaceutical	USD 340.02M	46.78M	2025-09
Vertex Pharmaceuticals	USD 3.86B	614.1M	2025-12
Xencor	USD 95.91M	9.42M	2025-12

PTC Therapeutics Passifs Courants - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Mar 2026.